European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Normal variation, population genetics, genetic epidemiology<br />
mictic population of Bucharest and the partial isolated population from<br />
Prahova Valley.<br />
Genetic distance analysis showed a close genetic relationship with<br />
Italian population as well as with Greek population groups.<br />
Historically this could be the result of intense trading activities of Thracian<br />
tribal groups and Greek population groups who established trading<br />
colonies at the west coast of the Black Sea (actually East-Romania)<br />
during the 7 th - 8 th century. The most of the Italian influence is thought<br />
to be the result of the occupation of the Danube region during the time<br />
of the Romanian Empire. A small Slavic influence was also found. The<br />
genetic distance between Romanian and German, Croatian, as well as<br />
Hungarian populations were more significant.<br />
The results can also be used for paternity and forensic analyses in the<br />
Romanian population.<br />
P1222. Beta Thalassemia in Iran: Genetic admixture, new<br />
theories for origin and migration of some mutations<br />
M. M. Banoei, M. Houshmand, M. Shafa Sharait Panahi;<br />
National Institute for Genetic Engineering and Biotechnology, Tehran, Islamic<br />
Republic of Iran.<br />
Background: Iran as one of the Middle East country consists of multiethnic<br />
groups that have been influenced by various invasions and<br />
migration throughout history. In the eastern Mediterranean region, Iran<br />
is one of the major centers for the prevalence of β- Thalassemia. This<br />
review is an attempt to study the origin of β- Thalassemia mutations in<br />
different parts of Iran.<br />
Methods: Through review and discussion of research literature and<br />
referred patients to our center, we compared the frequencies of β -<br />
globin mutations in different regions of Iran with those derived from<br />
neighboring countries.<br />
Results: The analysis provided evidence of new theories about the<br />
origin and migration of some mutations like -25bp del, CD36/37, CD30<br />
and introduction of IVSI-5 to outside, as well as, the remarkable genetic<br />
classification of the Iranian people and ethnic groups.<br />
Conclusions: This review represents reflection of historic events due<br />
to genetic admixture and roles of invasions and migrations in this phenomenon.<br />
Also distribution of β- globin gene mutations in Iran showed<br />
high heterogeneity among the population in comparison with other<br />
population that this heterogeneity has been derived originally from a<br />
population with an ethnic Aryan background.<br />
P1223. A Novel β-thalassemia mutation in the distal promoter of<br />
the β-globin gene<br />
I. Agouti 1 , C. Badens 2 , F. Sayah 1 , A. Barrakat 1 , M. Bennani 1 ;<br />
1 laboratoire de Biologie Appliquée, Faculté des Sciences et Techniques, Tanger,<br />
Morocco, 2 Laboratoire de Génétique Moléculaire, Hôpital de d’Enfant de la<br />
Timone, Marseille, France.<br />
A patient with β-thalassemia intermedia of Moroccan descent was<br />
found to be compound heterozygous for a novel β-thalassemia muta-<br />
tion G→A at position -<strong>19</strong>0 5’ to the β-globin gene and a previously<br />
described β 0 -thalassemia allele frame shift codon 6 (-A). The novel<br />
mutation was found to be associated with the Mediterranean β haplotype<br />
IX [- + - + + + +].<br />
The mother, who has the -<strong>19</strong>0 G→A mutation as the sole abnormality<br />
of the β-globin gene, had normal hemoglobin, red blood cell indices<br />
and HbA 2 levels. Thus the -<strong>19</strong>0 G→A mutation is silent.<br />
The possibility that the novel -<strong>19</strong>0 G→A substitution is a simple polymorphism<br />
in the β-globin gene was considered, but is unlikely given its<br />
presence in a region (-50 to -300) where other promoter elements important<br />
for differential control of gene expression have been described<br />
and the absence of this substitution in 80 other normal chromosomes.<br />
Although functional tests of the cloned gene in suitable expression assays<br />
will be needed to prove that the change at position -<strong>19</strong>0 is a mutation<br />
rather than a simple polymorphism.<br />
P1224. Allele frequencies of two novel tandem repeat<br />
polymorphism of the 5’-untranslate region of the human CYP2E1<br />
gene<br />
C. Gräbsch, O. Herbarth, H. E. Wichmann, U. Krämer, M. Bauer, the LISA<br />
study group;<br />
Helmoltz Centre for Environmental Research - UFZ, Department for <strong>Human</strong><br />
Exposure Research and Epidemiology, Leipzig, Germany.<br />
The ethanol inducible human cytochrome P4502E1 (CYP2E1) plays<br />
a key role in the metabolic activation of procarcinogens like aniline,<br />
vinyl chloride as well as acryl amide. CYP2E1 activity depends on<br />
inter-individual genetic polymorphisms as well as on interactions at<br />
translational level. Homozygotes for CYP2E1*1D allele have got an<br />
increased enzyme activity compared to the CYP2E1*1C allele.<br />
In order to examine the relationship between pollutant -induced clinical<br />
outcomes and genetic polymorphisms 1003 Caucasians of the LISA<br />
epidemiological study were genotyped for enzymes of biotransformation.<br />
Regarding CYP2E1, a repeat in the 5’-untranslated region at -2178<br />
to -<strong>19</strong>45 bp has been analyzed in more detail by allele specific PCR.<br />
Besides the expected alleles CYP2E1*1A (5 repeats), CYP2E1*1C (6<br />
repeats, wt) and CYP2E1*1D (8 repeats) with a frequency of 0.4%,<br />
97.4% and 2.1%, two novel alleles could be described by the present<br />
work.<br />
The first novel allele (Acc-No. AM503355) contains 7 repeats and appears<br />
with a frequency of 0.05%. This allele is heterozygous expressed<br />
with the CYP2E1*1C.<br />
The second novel allele contains 8 repeats and exclusively appears<br />
concomitantly with the CYP2E1*1D allele (frequency 2.1%), which is<br />
heterozygous expressed mainly with the CYP2E1*1C or rarely with<br />
the CYP2E1*1A allele. At the moment it is not clear whether the novel<br />
polymorphisms of the 5’-flanking region alter the CYP2E1 expression.<br />
0